There has been a big jump in the number of generic products whose acquisition cost is greater than the new category M January prices. This may be due to a combination of factors, including the reduction in reimbursement price of 621 Category M products, as well as inflationary pressures due to supply issues.
Dispex publishes an updated monthly list of Generics Costing more than Tariff and there are 135 products on the list. When you take the Discount Abatement (Clawback) into consideration, this number jumps to 225 products!
Dispex Informatics has produced a guide to assist you to deal with these potential losses – Generics Costing More Than Tariff, and Concessions – a Dispex Solution!
Members can login to read in full: